Mutations in the Laminin 5 LAMB3 Gene in Generalized Atrophic Benign Epidermolysis Bullosa  by Anton-Lamprechet, I. et al.
856 LETTERS TO T H E ED ITOR 
REPLY 
We do not believe there is a controversy regarding our published 
conclusion [1] that the m alignant T cell s in cutaneous T-cell 
lymphom a (CTCL) most closely resemble murine T -helper type 2 
cell s. Our overall findings dea lt with' cytokine networks that were 
established in patients w ith d iffe rent clinica l manifestations of 
CTCL. Many diverse cell types contribute to the establishment of 
such networks including endogeno us cell s of the skin as w ell as 
recrui ted benign reactive T cells and malignant T cells. D espite 
widely dive rgent clinical presentations and the confederacy of cell 
types that can produce cytokines, it was clear that reproducible 
patterns of cytokin e networks were present in the epidermal and 
derm al compartments of CTCL patients . In o ur report we pre-
sen ted three possible explanations for the RT-PCR-based results 
in w hich skin biopsies of mycosis fungoides lesions were found to 
contaiy cytokines closely resembling the murine T -helper type 1 
re)ponse, whereas Sezary syndrome samples had cytokin es closely 
resembling the murine T helper type 2 response. Our first and 
favored conclusion of these results, as mentioned above [1], was: 
"The first of these is that aLI mali gnant T ce LI s in CTCL arc ofTh2 
type . .. " We believe th at this sentence , conveys the same message 
as the letter of Lessin el a/. Indeed , we had previously o bserved in 
1989 the inabili ty of circulating Sezary cells to produce IFN-')I [2], 
which supports o ur contention that the malignant tumor cell s 
belong in the category of the T -helper type 2 cells. M ore recentl y, 
usin g immunostaining we locali zed an important Th-2 type cyto-
kine, IL-10, to the malignant T cells ill 1I i1)D and to a Sezary cell lin e 
ill lI il l'o [3 ,4]. 
We believe that the cytokine prod uction p rofile of an individual 
T cell could be influenced by loca lmicroen vironmental factors. W e 
have demonstrated that local facto rs such as the nature of the 
antigen-presenting ce ll (APC) ca n signifi can tly determine whether 
a T-cell-prolife rative response is accompanied by a T h-1 type 
versus T h-2 type cytokine production profi le [5]. Using resting 
peripheral blood-derived T cell s and an identica l antigenic stimulus 
(bacterial-derived superantigen-relevant to CTCL r6]) , a T h-2 type 
cytokin e profi le results if keratinocytes were used as the " n on-
professional" type of APC, whereas a Th-l type cytokine response 
was produced using dermal dendritic ce ll s as the " professional" 
type of APC (7]. Because the T h-2 response could be con verted to 
a T h-1 type response by adding IL-12, we explored the poss ibl e 
in volve ment o flL-1 2 in CTCL. In a study that is currently subitted 
for publication, we h ave observed that treatment regimens used for 
CTCL such as photopheresis and psoralen plus ultrav io let A grea tly 
increased rL-12 levels, w hi ch cou ld retard the pro li feration of the 
malignan t T h-2 type ce ll s. Another in triguing observation re levant 
to the characte rization of the malignant T cells in CTCL [8] had 
been the recognition tha t these cells co-express CD28 and the 
co- stimulatory m o lecule B7-1 (CD80). Such dual expression could 
facilitate autostimulation between malignan t T cell s and lead to 
their proliferation becoming independent of the necessity fo r 
interaction with APCs to prov ide co- stimulation. At least on e 
report has demonstrated when T cells inte ract with APCs in a 
CD28:B7-dependent fashion that a T h- 1 type response ensued , 
whereas, if this pathway is blocked, a T h-2 type response occurs 
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[9] . T hus, it is possible that by acquIrIng co-express ion of both 
ligand and receptor (CD28 and B7-1) the malignant T - cell clone 
could perpetuate itselfin an APC-independent fashion and produ ce 
predo min antl y T h-2 type cytokines . A recent abstract [10] demon-
strates that cu ltu red Sezary cells utilize C D 28 mediated co-stimu-
lation fo r the if pro liferation, although no ill I) ill"o cytokine produc-
tion profi les were indica ted . 
M an y new and exciting revelation s regarding the immunology 
and pathophysio logy of CTCL are em erging. Microenviro l1m ental 
factors may be important in CTCL, and th e Th-2 type nature of 
malign ant T - cell clones m ay well represen t the coll ective influence 
of neighbbOl;ng professional and non-professional APCs (keratino-
cytes and dendritic cells), via the ir expressio n of re levant co-
stimulato ry signal s (mediated via CD28) and production of cyto-
kines (IL-10 and IL-12) . Such new insights may lead to a better 
understanding of the factors that are important in the em ergence of 
such m aLign ant T ce lJ clones ;11 1) ; 110 and to better success in 
propagating these T h-2 type cells ill IJilro . 
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Mutations in the Laniinin 5 LAMB3 Gene in 
Generalized Atrophic Benign Epidermolysis Bullosa 
To the Edito r: 
I h ave read with interest the paper of M cG ra th ci tI/ [1] in the Apri l 
1995 issue and con gratul ate the authors, especially Drs. C hristiano 
and Uitto , for successfull y identifyin g th e mu tations in domain VI 
of the lam in in 5 {33 chain sho rt arm as underlying m o lecular defects 
in their fa mil y with th e no n-lethal mitis type of junctional ED. 
N evertheless, I would like to comment on the authors' citation 
m ode stating that this type of junctional ED had been described fo r 
the fIrst time by Hintner and Wolff in 1982 [2] . T his is not correct. 
In f.1 ct, the first case of this beni gn, non-lethal junctional ED type in 
the world li terature had been reported by Hashimoto ci tI/ in 1976 
[3], delineating this form as a distinct variant of ED and describing 
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all c harac te ristic features clinically and by EM that were later 
confi rmed by Hintl1 er and Wolff. This 1976 paper was publishcd in 
English so that British and Ameri can colleagues also would not 
hav e had difficulties in rea ding it. 
Hintner and Wolff, in their 1982 publi cation [2], not on ly 
poin ted hon es tl y to this first casc but stressed that further cases had 
been reported by Schnyder and Anton-Lamprecht (1979) [4] and 
that they had sugges ted the term "ep idcrmolysis bullosa atrophi-
cans gencralisata mitis ... for this ncw ly delineatcd variant" (page 
375 in [2]). Thjs tcrminology has bccn used further on [5-9] and 
was adopted by Hintner and Wolff, who, in their carefully preparcd 
1982 paper [2], have just trans lated the scientifi c Latin tcrm into the 
A.n.glo-Amcrican version. 
During our systematic work with EB since abo ut 1970, with 
presently more than 620 cases of Ell ana lyzed and diagnosed by 
EM, we have frequently been en countered with this mild, non-
le thal mitis type of junctional Ell, and a total of 37 cases have by 
nOVV (April 1995) bccn identitied by EM (Dccembcr, ] 994: EB total 
616. EB junctional 187 = 32.3')/0 , including Herlitz 110 = 19'X, and 
rnitis 33 = 5.7%). In the lite rature it has been stressed that only the 
lon g -term coursc should determine the mitis type clinically 
[2,9.10]. Thi s is not the case: the mitis type of junctional EB can be 
ide n tified by EM already in the nconate [8] and clinica ll y in small 
c hildren by distin ct differences from the Herlitz type (Anton-
Lan'lp rccht and Ebschn er, to be submitted) . These ex periences are 
further underlin cd by the present idcntifi cation of the spccific 
LAMll3 gcne mutati ons in the mitis type. 
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R E PLY 
We would like to thank Profcssor Anton-Lamprech t fo r her 
inte rest in o ur recentl y published work [1], and for h er insi g htful 
comments on generalized atrophic benign epiderm olysis bullosa 
(GAllEll). It was not o ur intention , by any mcans, to ign o rc the 
work reported by Hashimoto el al [2] and by Schnyder and Anton-
Lamprecht [3], and, in f.1ct , these two references werc included in 
our Ol'ig inal publication. In our paper w e stated that GAllEll is a 
ra~'e form of non-l ethal junctional EB. and was first reported It"iltg 
IllIs llOlII ellclalllrc by Hintner and WolfF [41. We believe that thi s 
statement is ind eed correct. 
Concern ing mutati ons in GAllEB, in addition to the LAMB3 
mutation reported in the April 1995 issue of JID [1] , we have 
recently disclosed compo und heterozygous mutations in the gene 
(BPAG2) en codll1g the 180-kD bullous pemphigoid antigcn. also 
known as type XV II collagen (C0L17 A 1) [51. Furthernlore, we 
ha ve recentl y identifi ed BPAG2 mutations [61 in the GAllEB fami ly 
reported by Hintn er and Wolfrin 198 2, The la tte r paper details th e 
chronol ogy of delineation of GABEB as a clinica lly distinct subtype 
of non-lethal junctional EB. 
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